Oral Abstract Session:
136. New Considerations for Improved Treatments of Community Infections
Friday, October 4, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 220-226

Learning Objectives:

-

Tracks: Adult ID, Epidemiology and Infection Control

Moderators:  Neil O. Fishman, MD, University of Pennsylvania and David Andes, MD, University of Wisconsin

Presentations:

2:00 PM
Comparing Preauthorization vs. Prospective Audit with Feedback for Antimicrobial Stewardship
Jimish M. Mehta, PharmD ; Kevin Haynes, PharmD, MSCE ; E. Paul Wileyto, PhD ; Ebbing Lautenbach, MD, MPH, MSCE ; Jeffrey S. Gerber, MD, PhD ; Neil O. Fishman, MD ; Theoklis Zaoutis, MD, MSCE

2:15 PM
Community Acquired Pneumonia (CAP) Treatment Guidelines for Hospitalized Adults: Is it Time for Reappraisal?
Joseph Mcbride, MD ; Kathy Mckinley, BS ; Paul Schreckenberger, PhD ; Malliswari Challapalli, MD

2:30 PM
Molecular melting curve analysis demonstrates that 9% of Mycoplasma pneumoniae strains in Central Ohio are macrolide resistant
Christine Zamastil, MD ; Octavio Ramilo, MD ; Douglas Salamon, MB(ASCP)SV ; Kathy Everhart ; Amy Leber, PhD ; Mario Marcon, PhD

2:45 PM
Time from Last Antibiotic Exposure as a Predictor of Antimicrobial Resistance in Invasive Pneumococcal Disease (IPD)
Allison Mcgeer, MD, MSc, FRCPC, FSHEA ; Karen Green, MSc ; Stefan P. Kuster, MD ; Altynay Shigayeva, PhD ; Wallis Rudnick, MSc ; Don Low, MD

3:00 PM
Sub Inhibitory Concentrations of Ceftriaxone (CRO) Revert Daptomycin Resistance (DAP-R) in Enterococcus faecalis
Jose Munita, MD ; Jinnethe Reyes, BSc ; Truc Tran ; Diana Panesso, MSc ; Cesar Arias, MD, PhD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

N. O. Fishman, None

D. Andes, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.